Skip to main content

Crown wraps up its case at Robert Charnock murder trial

Share

The Crown completed its case at the second-degree murder trial of 42-year-old Robert Charnock Tuesday at the London, Ont. courthouse after calling a doctor from the St. Thomas psychiatric hospital.

Charnock is accused of killing his one-time friend in December of 2021.

Both he and the victim, 56-year-old Kenneth Wallis were tenants at a Wharncliffe Road rooming house when Wallis died after suffering deep lacerations.

During the trial, the court heard that Charnock suffers from mental health issues along with having an anti-social personality disorder.

However, Dr. Jason Quinn, who interviewed Charnock and compiled a 43-page report, testified, “My conclusion is that, from a psychiatric perspective, Mr. Charnock does not have the defence of not criminally responsible.”

The doctor went on to say, “[Charnock] was attempting to persuade me that he had this illness, schizophrenia, and that was responsible for all of his violent past.”

The court has heard that Wallis and the accused were friends but that things changed after Charnock accused the victim of stealing from him and lacing his drugs with fentanyl.

Charnock has plead not guilty to second-degree murder.

The trial has now been adjourned until Friday.

Kenneth Wayne Wallis of London, Ont. is seen in this undated photo. (Source: Wayne Wallace / Facebook)

CTVNews.ca Top Stories

opinion

opinion 5 reasons not to invest in mutual funds

Traditionally, mutual funds have stood as a go-to investment strategy for those looking to grow their wealth without the effort of stock-picking. But financial columnist Christopher Liew outlines some reasons why mutual funds often aren’t the golden ticket they're made out to be, especially in Canada.

Trend Line

Trend Line Poilievre's Conservatives widen lead over Liberals: Nanos

The federal Conservatives have increased their support as the party Canadians would vote for and the Liberals are at a statistical tie with the New Democrats, according to the latest Nanos Research tracking.

Stay Connected